| Hans-Günter Meyer-Thompson | Hepatitiden
Reinfection following direct-acting antiviral therapy for hepatitis C infection among people in prison with recent injecting drug use: the SHARP-P study.
Reinfection following direct-acting antiviral therapy for hepatitis C infection among people in prison with recent injecting drug use: the SHARP-P study.
Conway A, Grebely J, Tillakeratne S, Cunningham EB, Munyengeterwa U, Van Dyk J, Martinello M, Carson J, Lafferty L, Bull RA, Horsburgh B, McGrath C, Brown T, Treloar C, Amin J, Degenhardt L, Applegate TL, Dunlop A, Matthews GV, Dore GJ, Lloyd AR, Hajarizadeh B.
Int J Drug Policy. 2026 Mar 19;151:105234. doi: 10.1016/j.drugpo.2026.105234. Epub ahead of print. PMID: 41861507.
https://www.sciencedirect.com/science/article/pii/S0955395926000861